Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP)

Shad H. Deering, Amy R. Stagg, Catherine Y. Spong, Kabir Abubakar, John C. Pezzullo, Alessandro Ghidini

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Objective. To determine if antepartum administration of magnesium sulfate affects the Score for Neonatal Acute Physiology (SNAP). Methods. We reviewed a database of consecutive preterm admissions to our neonatal intensive care unit over a 12-month period. Information on delivery indication, magnesium sulfate use, betamethasone administration, neonatal SNAP scores, neonatal serum magnesium levels, and other data was collected. Data was analyzed by Chi-square, Student t-test, and multiple linear regression with P < 0.05 considered significant. Results. During the study period, 221 cases fulfilled inclusion and exclusion criteria. Multiple regression revealed a significant association between antepartum magnesium use and improved SNAP scores after controlling for gestational age, glucocorticoid use, chorioamnionitis, and birthweight (SNAP score reduction = -2.25 ± 0.78, P = 0.005). Conclusions. Antepartum administration of magnesium sulfate results in a significant improvement in the neonatal SNAP score. These results suggest that antepartum magnesium sulfate may be protective, or at least not detrimental to the newborn infant.

Original languageEnglish (US)
Pages (from-to)151-155
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume17
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Magnesium Sulfate
Magnesium
Chorioamnionitis
Therapeutics
Betamethasone
Neonatal Intensive Care Units
Glucocorticoids
Gestational Age
Linear Models
Newborn Infant
Databases
Students
Serum

Keywords

  • Antepartum
  • Magnesium sulfate
  • SNAP

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP). / Deering, Shad H.; Stagg, Amy R.; Spong, Catherine Y.; Abubakar, Kabir; Pezzullo, John C.; Ghidini, Alessandro.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 17, No. 2, 02.2005, p. 151-155.

Research output: Contribution to journalReview article

Deering, Shad H. ; Stagg, Amy R. ; Spong, Catherine Y. ; Abubakar, Kabir ; Pezzullo, John C. ; Ghidini, Alessandro. / Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP). In: Journal of Maternal-Fetal and Neonatal Medicine. 2005 ; Vol. 17, No. 2. pp. 151-155.
@article{70a7c727f369491db3bdb3aafb04a93b,
title = "Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP)",
abstract = "Objective. To determine if antepartum administration of magnesium sulfate affects the Score for Neonatal Acute Physiology (SNAP). Methods. We reviewed a database of consecutive preterm admissions to our neonatal intensive care unit over a 12-month period. Information on delivery indication, magnesium sulfate use, betamethasone administration, neonatal SNAP scores, neonatal serum magnesium levels, and other data was collected. Data was analyzed by Chi-square, Student t-test, and multiple linear regression with P < 0.05 considered significant. Results. During the study period, 221 cases fulfilled inclusion and exclusion criteria. Multiple regression revealed a significant association between antepartum magnesium use and improved SNAP scores after controlling for gestational age, glucocorticoid use, chorioamnionitis, and birthweight (SNAP score reduction = -2.25 ± 0.78, P = 0.005). Conclusions. Antepartum administration of magnesium sulfate results in a significant improvement in the neonatal SNAP score. These results suggest that antepartum magnesium sulfate may be protective, or at least not detrimental to the newborn infant.",
keywords = "Antepartum, Magnesium sulfate, SNAP",
author = "Deering, {Shad H.} and Stagg, {Amy R.} and Spong, {Catherine Y.} and Kabir Abubakar and Pezzullo, {John C.} and Alessandro Ghidini",
year = "2005",
month = "2",
doi = "10.1080/jmf.17.2.151.155",
language = "English (US)",
volume = "17",
pages = "151--155",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP)

AU - Deering, Shad H.

AU - Stagg, Amy R.

AU - Spong, Catherine Y.

AU - Abubakar, Kabir

AU - Pezzullo, John C.

AU - Ghidini, Alessandro

PY - 2005/2

Y1 - 2005/2

N2 - Objective. To determine if antepartum administration of magnesium sulfate affects the Score for Neonatal Acute Physiology (SNAP). Methods. We reviewed a database of consecutive preterm admissions to our neonatal intensive care unit over a 12-month period. Information on delivery indication, magnesium sulfate use, betamethasone administration, neonatal SNAP scores, neonatal serum magnesium levels, and other data was collected. Data was analyzed by Chi-square, Student t-test, and multiple linear regression with P < 0.05 considered significant. Results. During the study period, 221 cases fulfilled inclusion and exclusion criteria. Multiple regression revealed a significant association between antepartum magnesium use and improved SNAP scores after controlling for gestational age, glucocorticoid use, chorioamnionitis, and birthweight (SNAP score reduction = -2.25 ± 0.78, P = 0.005). Conclusions. Antepartum administration of magnesium sulfate results in a significant improvement in the neonatal SNAP score. These results suggest that antepartum magnesium sulfate may be protective, or at least not detrimental to the newborn infant.

AB - Objective. To determine if antepartum administration of magnesium sulfate affects the Score for Neonatal Acute Physiology (SNAP). Methods. We reviewed a database of consecutive preterm admissions to our neonatal intensive care unit over a 12-month period. Information on delivery indication, magnesium sulfate use, betamethasone administration, neonatal SNAP scores, neonatal serum magnesium levels, and other data was collected. Data was analyzed by Chi-square, Student t-test, and multiple linear regression with P < 0.05 considered significant. Results. During the study period, 221 cases fulfilled inclusion and exclusion criteria. Multiple regression revealed a significant association between antepartum magnesium use and improved SNAP scores after controlling for gestational age, glucocorticoid use, chorioamnionitis, and birthweight (SNAP score reduction = -2.25 ± 0.78, P = 0.005). Conclusions. Antepartum administration of magnesium sulfate results in a significant improvement in the neonatal SNAP score. These results suggest that antepartum magnesium sulfate may be protective, or at least not detrimental to the newborn infant.

KW - Antepartum

KW - Magnesium sulfate

KW - SNAP

UR - http://www.scopus.com/inward/record.url?scp=20044372780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044372780&partnerID=8YFLogxK

U2 - 10.1080/jmf.17.2.151.155

DO - 10.1080/jmf.17.2.151.155

M3 - Review article

C2 - 16076625

AN - SCOPUS:20044372780

VL - 17

SP - 151

EP - 155

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 2

ER -